» Articles » PMID: 34595945

Validation of EHR Medication Fill Data Obtained Through Electronic Linkage with Pharmacies

Overview
Specialties Pharmacology
Pharmacy
Date 2021 Oct 1
PMID 34595945
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Recent linkages between electronic health records (EHRs) and pharmacy data hold opportunity for up-to-date assessment of medication adherence at the point of care. To validate linked EHR-pharmacy data, which can be used for point-of-care interventions for concordance with insurance claims data for patients in a large health care delivery system. We performed a retrospective cohort study of adult patients with an active antihypertensive medication order and seen as outpatients between August 25, 2019, and August 31, 2019. Pharmacy fill information was obtained from the EHR via linkages with Surescripts pharmacy and pharmacy benefit manager data, as well as from insurance claims available at our institution. We matched antihypertensive medication fills observed in the linked EHR-pharmacy database with available fills in the insurance claims database and calculated the percentage of medication fills that were available in each database. We estimated medication adherence using proportion of days covered in the linked EHR-pharmacy database and in the insurance claims database. Of 26,679 patients with hypertension, 23,348 (87.5%) had at least 1 antihypertensive medication fill recorded in the linked EHR-pharmacy database. Of 1,501 patients matched with the insurance database and with a documented medication fill, a fill was present for 1,484 (98.9%) and 1,259 (83.9%) patients in the linked EHR-pharmacy and insurance databases, respectively. Of 12,109 medication fills recorded in the insurance data, we found an overlap of 11,060 (91.3%) fills with the linked EHR-pharmacy database. The linked EHR-pharmacy database also contained 18,232 of 19,281 (94.6%) medication fills present in either database. Measured medication adherence was higher for patients when based on linked EHR-pharmacy data compared with insurance claims data (42% vs 30%, < 0.001). Linked EHR-pharmacy data captured medication fills for the vast majority of patients and resulted in higher estimates of adherence than insurance claims. Our results suggest that pharmacy fill data available in the EHR have sufficient reliability to be used for point-of-care assessment of medication adherence. This study was supported by grant R01HL155149 from the National Heart, Lung, and Blood Institute. Allen Thorpe provided funding for the NYU Langone Health Learning Health System Program, which helped fund this project. The authors have nothing to disclose.

Citing Articles

Linking Electronic Health Record Prescribing Data and Pharmacy Dispensing Records to Identify Patient-Level Factors Associated With Psychotropic Medication Receipt: Retrospective Study.

Wu P, Hurst J, French A, Chrestensen M, Goldstein B JMIR Med Inform. 2025; 13:e63740.

PMID: 40035724 PMC: 11895725. DOI: 10.2196/63740.


Impact of Social Determinants of Health on Primary Adherence of Oral Anticoagulants Among Patients with Newly Diagnosed Atrial Fibrillation.

Glowacki N, Guzman I, Mills J, Parks A, Ateya M, Dai F Cardiol Ther. 2025; 14(1):53-69.

PMID: 39752004 PMC: 11893941. DOI: 10.1007/s40119-024-00395-0.


Measurement of Completeness and Timeliness of Linked Electronic Health Record Pharmacy Data for Early Detection of Nonadherence to Breast Cancer Adjuvant Endocrine Therapy.

McPeek C, Paul S, Lieberenz J, Levy M JCO Clin Cancer Inform. 2024; 8:e2400115.

PMID: 39666913 PMC: 11658023. DOI: 10.1200/CCI.24.00115.


One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice.

Gasoyan H, Pfoh E, Schulte R, Le P, Butsch W, Rothberg M JAMA Netw Open. 2024; 7(9):e2433326.

PMID: 39269703 PMC: 11400221. DOI: 10.1001/jamanetworkopen.2024.33326.


Using linked electronic medical record-pharmacy data to examine lupus medication adherence: A retrospective cohort study.

Sun K, Wojdyla D, Shah A, Eudy A, Clowse M Lupus. 2024; 33(12):1299-1305.

PMID: 39226468 PMC: 11427133. DOI: 10.1177/09612033241280695.


References
1.
Kronish I, Ye S . Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013; 55(6):590-600. PMC: 3639439. DOI: 10.1016/j.pcad.2013.02.001. View

2.
Rashid N, Vassilakis M, Lin K, Kristy R, Ng D . Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System. J Manag Care Spec Pharm. 2017; 23(4):484-493. PMC: 10398132. DOI: 10.18553/jmcp.2017.23.4.484. View

3.
Martin B, Wiley-Exley E, Richards S, Domino M, Carey T, Sleath B . Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009; 43(1):36-44. DOI: 10.1345/aph.1K671. View

4.
Lauffenburger J, Franklin J, Krumme A, Shrank W, Matlin O, Spettell C . Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors. J Manag Care Spec Pharm. 2018; 24(5):469-477. PMC: 10397690. DOI: 10.18553/jmcp.2018.24.5.469. View

5.
Choo P, Rand C, Inui T, Lee M, Cain E, Canning C . Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999; 37(9):846-57. DOI: 10.1097/00005650-199909000-00002. View